Brevan Howard Capital Management’s Agilent Technologies A Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.2M Sell
16,580
-19,099
-54% -$2.33M 0.02% 678
2026
Q1
$4.07M Buy
35,679
+26,528
+290% +$3.37M 0.04% 315
2025
Q4
$1.25M Buy
9,151
+5,458
+148% +$784K 0.01% 668
2025
Q3
$474K Sell
3,693
-391
-10% -$47.2K ﹤0.01% 1319
2025
Q2
$482K Buy
+4,084
New +$453K ﹤0.01% 1370
2024
Q1
– Sell
-6,651
Closed -$925K – 962
2023
Q4
$925K Buy
6,651
+378
+6% +$45K 0.01% 261
2023
Q3
$701K Hold
6,273
– – 0.01% 124
2023
Q2
$754K Hold
6,273
– – 0.02% 107
2023
Q1
$868K Hold
6,273
– – 0.02% 87
2022
Q4
$939K Hold
6,273
– – 0.03% 59
2022
Q3
$762K Buy
6,273
+4,100
+189% +$527K 0.03% 55
2022
Q2
$258K Hold
2,173
– – 0.01% 45
2022
Q1
$288K Buy
+2,173
New +$299K 0.02% 30

Other funds holding A

Brevan Howard Capital Management's A Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its Agilent Technologies (A) stake by 54% in Q2 2026, selling an estimated $2.33M and leaving 16,580 shares worth $2.2M. The position accounts for 0.02% of the portfolio, ranked #678.

Brevan Howard Capital Management first reported a position in A in Q1 2022 and has held it in 13 quarters since. The position peaked at $4.07M in Q1 2026. 1,135 funds tracked by Wall St. Rank hold A as of Q2 2026.

  • Brevan Howard Capital Management held 16,580 shares of Agilent Technologies worth $2.2M as of Q2 2026.
  • Brevan Howard Capital Management sold 19,099 Agilent Technologies shares in Q2 2026, an estimated $2.33M.
  • Agilent Technologies made up 0.02% of Brevan Howard Capital Management's portfolio in Q2 2026, its #678 holding.
  • Brevan Howard Capital Management first reported a position in Agilent Technologies in Q1 2022 and has held it in 13 quarters since.
  • Brevan Howard Capital Management's Agilent Technologies position peaked at $4.07M in Q1 2026.
  • 1,135 funds tracked by Wall St. Rank held Agilent Technologies as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.